Become a Creator today!Start creating today - Share your story with the world!
Start for free
00:00:00
00:00:01
Neurologic Criteria for Death in Adults image

Neurologic Criteria for Death in Adults

Critical Matters
Avatar
5 Plays6 years ago
For a long time death has been understood as the cessation of cardiopulmonary function. With the advent of mechanical ventilation and life support in the ICU, the concept of brain death emerged. In this episode of Critical Matters, we discuss the determination of death by neurologic criteria. Our guest is Dr. Fred Rincon, Associate Professor of Neurology and Neurological Surgery at Thomas Jefferson University in Philadelphia. Additional Resources: The most recent update to the evidence-based guidelines for determining brain death in adults: https://bit.ly/2TXjSZr Web-based toolkit and educational material for clinicians on brain death: https://bit.ly/2FA7KVj Previous episode of Critical Matters with Dr. Rincon where we discussed neuroprognostication after cardiac arrest: https://bit.ly/2JHFZ1q Books and Albums Mentioned in This Episode: Meditations by Marcus Aurelius: https://amzn.to/2FD1xIy Nevermind by Nirvana: https://amzn.to/2WmVVYd
Transcript

Introduction to 'Critical Matters' Podcast

00:00:09
Speaker
Welcome to Critical Matters, a sound critical care podcast covering a broad range of topics related to the practice of intensive care medicine.
00:00:17
Speaker
And now, your host, Dr. Sergio Zanotti.

What is Brain Death? Advances and Concepts

00:00:23
Speaker
Death is universal.
00:00:24
Speaker
It is one of the few constants throughout human history.
00:00:27
Speaker
For a long time, death has been understood as the cessation of cardiopulmonary function.
00:00:32
Speaker
With the advent of mechanical ventilation and life support in the ICU, the concept of brain death has emerged.
00:00:39
Speaker
Today, we understand brain death as death of the individual due to irreversible loss of function to the entire brain.
00:00:46
Speaker
The determination of brain death is still fraught with this understanding both from clinicians and from the lay public.
00:00:52
Speaker
Today we will discuss the neurologic criteria for determining death in adults.
00:00:56
Speaker
We will talk about brain death or death by neurologic criteria.
00:01:00
Speaker
Our guest is Dr. Fred Rincon, a repeat guest for the podcast.

Meet Dr. Fred Rincon: Credentials and Experience

00:01:05
Speaker
Dr. Rincon is Associate Professor of Neurology and Neurological Surgery in the Division of Neurotrauma and Critical Care at the Department of Neurological Surgery at Thomas Jefferson University in Philadelphia.
00:01:17
Speaker
He is board certified in internal medicine and critical care, neurology, vascular neurology, and neurocritical care.
00:01:24
Speaker
He's a fellow of the American College of Physicians, the American College of Chest Physicians, and the American Heart Association, and a member of the Society of Critical Care Medicine, Society of Neurocritical Care, and the American Academy of Neurology.
00:01:36
Speaker
Fred, welcome back to Critical Matters.
00:01:40
Speaker
It's my pleasure, Sergio.
00:01:41
Speaker
Thank you for having me here.

Historical Perspectives on Death and Brain Death

00:01:43
Speaker
So last time you were here a little bit over a year ago, we talked about neuroprognostication in patients who underwent targeted therapeutic hypothermia after cardiac arrest.
00:01:54
Speaker
Today, I think we're going to talk about a situation that might arise in this patient, but it's much more common in other situations, which is brain death or death by neurologic criteria.
00:02:05
Speaker
So I think that a good place to start would be to maybe provide us a little bit of a historical perspective.
00:02:11
Speaker
As I mentioned in the intro, we have traditionally understood death as being the cessation of cardiopulmonary function.
00:02:19
Speaker
But really, in the 20th century, with the emergence of critical care and life support, this concept of brain death emerges.
00:02:26
Speaker
Can you tell us a little bit about the history of this?
00:02:28
Speaker
When did this

Evolution of Brain Death Criteria

00:02:29
Speaker
happen, Fred?
00:02:29
Speaker
Fred?
00:02:31
Speaker
So traditionally, we were used to the concept of death on the basis of cardiopulmonary failure.
00:02:38
Speaker
And that's sort of like, you know, it's sort of like, you know, when you look at this philosophically and medically, you know, you start reading all these reports and textbooks, you know, sort of like the cessation of pulse and cardiac function.
00:02:53
Speaker
and respirations was the sort of like indicator of death and the coming of death.
00:03:01
Speaker
And that's how we define it classically.
00:03:03
Speaker
But around 1960, physicians throughout the world, including the United States,
00:03:11
Speaker
By the way, the first ones that describe this concept were the French.
00:03:17
Speaker
They started looking at these patients that had catastrophic brain injury and they ended up on mechanical ventilation for a while.
00:03:27
Speaker
So it sort of became a phenomenon around 1968 when the first reports started to come in the literature.
00:03:36
Speaker
If you look at the first reports in France, they described this as coma de passe or past coma, something like that.
00:03:46
Speaker
So there were all these patients with brain injury that didn't have any brain activity, no brainstem reflexes, no consciousness.
00:03:56
Speaker
They were pretty much in a coma attached to mechanical ventilation and artificial life support.
00:04:00
Speaker
They start questioning, you know, what are we going to do with these patients?
00:04:04
Speaker
You know, they're just like, you know, filling our words and our rooms.
00:04:09
Speaker
And that's when the first sort of like concepts start to emerge about death by neurological criteria.
00:04:16
Speaker
And then they start doing all these electrophysiological studies that showed specific pattern that we see when we request continuous EEGs in these patients.
00:04:27
Speaker
This is this
00:04:28
Speaker
electro, physiological silence, sort of like the description of it.
00:04:36
Speaker
And then they start sort of questioning if they could use or develop a concept of death on the basis of cessation of whole brain function.
00:04:47
Speaker
And that's what led to Harvard investigators to start gathering information about the natural course of this condition.
00:04:58
Speaker
And on the basis of that, the United States started to look in more detail and assemble a group of experts and investigators and try to look at this more in detail and to provide more definitions about what needed to be done in order to arrive to a conclusion of that on the neurological criteria.
00:05:23
Speaker
And that's what you see in the 1970s, sort of the first guideline in the United States by the Harvard Group.
00:05:31
Speaker
And then finally, the UDDA, or the Uniform Determination of Death Act, which was commissioned by the president in the late 70s and then in 1981, what defined death in the United States jurisdiction on the basis of both cardiac and neurological criteria.
00:05:50
Speaker
So, you know, basically what the UDDA says is that the expertise and the way that you arrive to this definition of death and the neurological criteria is on the provider, on the physician's

Clinical Steps in Determining Brain Death

00:06:05
Speaker
side.
00:06:05
Speaker
It didn't tell how to do it or, you know, or...
00:06:10
Speaker
or the specific criteria that needed to be considered, it just said, you know, that it needed to be done by the providers themselves.
00:06:19
Speaker
And we arrived to a definition, it's sort of like a determination of what needed to be done to arrive to that conclusion.
00:06:28
Speaker
It was basically a very simple thing, you know, had catastrophic brain injury, you know, followed by, you know,
00:06:38
Speaker
a comatose state and absence of brainstem reflexes.
00:06:41
Speaker
And then we sort of like define more how to approach that disease state over the following 20 years.
00:06:48
Speaker
And that's sort of like the historic snapshot, right, of how we arrive to this conclusion and to this syndrome that we see nowadays after catastrophic brain injury in the intensive care unit.
00:07:02
Speaker
And I think it's important because this is obviously not a
00:07:06
Speaker
old history, but considering relatively new with the advent of the development of ICUs.
00:07:11
Speaker
But like you said, just to recap, the first guidelines really came in the United States from the group in Harvard in 1968 and legislation at a federal level.
00:07:22
Speaker
with the Uniform Determination of Death Act in 1991 established that you could be pronounced dead either by cardiopulmonary criteria or by neurologic criteria.
00:07:32
Speaker
But what the legislation stated, like you said, Fred, was that that was based on a medical standard.
00:07:37
Speaker
So they really left the court or the legislators left the medical standard to be determined by clinicians and by societies.
00:07:46
Speaker
So I think that, as you mentioned earlier, there are some
00:07:51
Speaker
classical or simple elements that have to be part of that initial determination.
00:07:58
Speaker
Why don't we dive a little bit more into the determination of brain death?
00:08:01
Speaker
And as you mentioned, you talked about the clinical evaluation of coma and some prerequisites.
00:08:07
Speaker
the absence of brainstem reflexes, and then apnea testing.
00:08:10
Speaker
And tell us how, from the guidelines that were published in 1995 forward, how do we really think at the bedside, what should be the first steps that we should take as intensivists or neurointensivists in determining if a patient is brain dead?
00:08:27
Speaker
Yes, so that's very important.

Variability in Brain Death Guidelines

00:08:29
Speaker
I think what you mentioned about how
00:08:32
Speaker
the attorneys or the judges sort of like left this to the providers, right?
00:08:39
Speaker
How we were going to define this syndrome is extremely important because
00:08:45
Speaker
you know, for future discussions, and it's very important for me to say this up front, is that, you know, we arrived at these conclusions on the basis of expertise, not on the basis of empiric data.
00:08:56
Speaker
So we basically determine certain things which I will mention, you know, what are the prerequisites for the clinical evaluation, you know, what are the sort of like guidelines in the United States.
00:09:09
Speaker
And by the way, when I say guidelines in this jurisdiction, that's an extremely important thing.
00:09:13
Speaker
because the American Academy of Neurology has these criteria and that's the criteria that we use at the point of care at the bedside.
00:09:22
Speaker
It's different, like if you cross borders, it's different in Europe, it's different in Asia, and it's very different, for example, in Latin America.
00:09:31
Speaker
But most of these jurisdictions sort of like adopt the same things that we interpret here in the United States, sort of like the American Academy of Neurology.
00:09:43
Speaker
You come to a question about is this patient brain dead when you have somebody with catastrophic brain injury.
00:09:50
Speaker
So like the most important thing is that you identify that there is a massive injury to the brain that would not be compatible with life otherwise.
00:10:02
Speaker
And then you start examining the patient.
00:10:04
Speaker
And the first thing that you have to document is absence of consciousness.
00:10:09
Speaker
So is the patient comatose or not?
00:10:12
Speaker
And if the patient is in a coma, then you can see you build your case by examining the patient.
00:10:17
Speaker
And what you do when you're examining the patient is, by the way, examining primarily the brainstem because there's no way of documenting, you know,
00:10:28
Speaker
you know, is the patient thinking, you know, unless you fight or is the patient experiencing sensations unless you are a seasoned, you know, examiner, neurologist that can pick up, for example, pitfalls, you know, like, for example, a patient with a, you know,
00:10:45
Speaker
locked-in syndrome, how to communicate with a patient that looks comatose that is not in reality comatose.
00:10:49
Speaker
But that's part of another discussion.
00:10:51
Speaker
So the second thing is to document total absence of brainstem reflexes.
00:10:55
Speaker
And you have to do a thorough neurological exam at this level.
00:11:00
Speaker
So you start with the pupils, you start with the reaction to corneal stimulation, you look at the absence of movements of the eyes with stimulation by either movement
00:11:13
Speaker
of the head if the patient doesn't have neck injury or by stimulation with caloric testing of the vestibular center.
00:11:23
Speaker
So sort of what we call cold caloric.
00:11:25
Speaker
And you continue going down the different levels of the brainstem.
00:11:31
Speaker
Then you check for the gag and the cough.
00:11:33
Speaker
And then finally, you have to test the lower segments of the medulla so you make sure that there is no movements of the neck or
00:11:43
Speaker
or abnormal posturing when you stimulate different levels.
00:11:48
Speaker
And this is an important aspect of the neurological exam is that you have to examine the patient above and below the foramen magnum.
00:11:57
Speaker
So this is a concept that sometimes doesn't get translated very well.
00:12:01
Speaker
It's what is the reaction with a painful stimulation on a finger or a toe or
00:12:08
Speaker
or a segment lower than the foramen magnum, and what happens when I examine the patient above the foramen magnum, because you have to see absence of total responses with both.
00:12:17
Speaker
So what happens when I stimulate the V1 to V3 painful areas, right?
00:12:24
Speaker
It has to be total absence.
00:12:26
Speaker
Then once you document that there's really no response
00:12:30
Speaker
to your, during your physical exam, and you document there's total absence of brainstem reflexes, then you try to confirm that there's really no
00:12:42
Speaker
response to a stimulation whatsoever and you do this with a apnea test which is a co2 challenge at the bedside.
00:12:52
Speaker
So Fred, before we go to the apnea test, I mean I think I want to dive in a little bit further into this first step which I think is very important and that may be a not as problematic for our neurology and neurocritical care colleagues but maybe something that some of our general critical care
00:13:11
Speaker
colleagues might need a little bit of reminder.
00:13:14
Speaker
So before we go to the apnotist, like I said, I want to dive in a little bit more.
00:13:18
Speaker
So first, could you just enumerate for us some of the prerequisites before we do this exam?
00:13:25
Speaker
So there are certain conditions, obviously, that we must make sure before we start doing this exam, because under certain conditions like heavy anesthetic or neuromuscular blockers, we might have what seems to be an exam consistent with
00:13:36
Speaker
brain death, but that could be problematic.
00:13:38
Speaker
So could you first tell us some of the prerequisites before we even attempt the exam?
00:13:43
Speaker
Yes, that's extremely important.
00:13:45
Speaker
So you have to make sure that there are no confounders during your exam.
00:13:49
Speaker
And the first thing that you make sure is that the patient's blood pressure is, for example, adequate, that the temperature is normal, that the patient is not hypothermic.
00:13:59
Speaker
You document that there is no metabolic disarray.
00:14:02
Speaker
You make sure that
00:14:03
Speaker
the sodium and the glucose are within normal limits, that there are no exposures to sedatives or analgesics that could cloud your neurological exam.
00:14:14
Speaker
In this sense, you need to also make sure that if you have had a patient that has been exposed to a metabolic problem or sedatives or analgesics, that the renal function, for example, and the
00:14:27
Speaker
liver function, are sort of close to normal because otherwise you have to consider half-lives of medications before you end up doing a brain-dead exam.
00:14:35
Speaker
You have to be extremely careful.

Conducting Apnea Tests for Brain Death

00:14:37
Speaker
This is extremely important before you try to determine if somebody's brain-dead is that.
00:14:43
Speaker
All these variables are checked.
00:14:46
Speaker
So we have a checklist, and if you go to the American Academy of Neurology,
00:14:51
Speaker
They provide a checklist that you could use and apply in your protocols.
00:14:56
Speaker
I can give you the link to those papers.
00:14:59
Speaker
And it's very clear, you know, what happens when the patient has been exposed to pentobarbital.
00:15:05
Speaker
What is the level of pentobarbital, for example?
00:15:08
Speaker
that is accepted for a brain dead examination.
00:15:11
Speaker
So all of that is extremely important.
00:15:14
Speaker
Normal oxygenation, a normal CO2 level, and there are some prerequisites, for example, in that case for COPD patients that have chronic respiratory acidosis, for example.
00:15:25
Speaker
So it's just to make sure that your exam is not confounded by anything.
00:15:31
Speaker
And you mentioned drug half-lives.
00:15:35
Speaker
What would be a general guideline
00:15:38
Speaker
in terms of time for how many half-lives would you wait in general with normal renal and hepatic function?
00:15:46
Speaker
It's usually five half-lives, the ones that you need to consider.
00:15:51
Speaker
And that's if your kidneys are normal.
00:15:53
Speaker
So if somebody has renal failure or liver failure, you have to be even more careful.
00:16:00
Speaker
You may need to wait even longer.
00:16:02
Speaker
So, you know, it's...
00:16:06
Speaker
The recommendation by the AN guideline is five half-lives.
00:16:09
Speaker
So at least five half-lives in general.
00:16:11
Speaker
And also you mentioned, like, for example, with penobarbital, you can check actually levels.
00:16:16
Speaker
And I think there are levels that are recommended and will include the document you referred to in the show notes.
00:16:23
Speaker
Also for alcohol, you could measure alcohol levels as well.
00:16:26
Speaker
So these are things that I think just to make sure that there's no confounding effects.
00:16:30
Speaker
I mean, a common...
00:16:31
Speaker
Seeing maybe some of our severe patients with ARDS is the use of neuromuscular blockers.
00:16:35
Speaker
So making sure that those are out of the system, you can do a train of four and you would expect a four out of four stimulation.
00:16:41
Speaker
So all these things, like you said, that are just a part of a checklist to make sure that our exam is not confounded by external factors that are reversible.
00:16:50
Speaker
Correct.
00:16:50
Speaker
I also wanted to dive in a little bit deeper, Fred, in the exam itself because I do think that there are some maybe subtleties that are sometimes missed to the non-neurologist.
00:17:02
Speaker
So you did mention the evaluation of the pupils, I mean reactivity to light, how that happens.
00:17:10
Speaker
Any comments on the oculosephalic reflex?
00:17:13
Speaker
So I think that something that I have noticed is that very often people
00:17:18
Speaker
clinicians who are not neurology trained will only do a horizontal, but they don't do a vertical oculocephalic test.
00:17:25
Speaker
Any comments on that?
00:17:27
Speaker
Yes.
00:17:27
Speaker
So, yeah, sort of the classic testing of horizontal line movements, right?
00:17:33
Speaker
The structures that control the horizontal line movements are primarily located in the pumps, you know, so the PPRF, the parapointing reticular
00:17:43
Speaker
formation and then also the sixth nerve, for example, and then the connection system between that and the third nerve.
00:17:49
Speaker
So that, it's primarily in the palms and in the midbrain.
00:17:54
Speaker
But vertical eye movements are a little different.
00:17:58
Speaker
The third nerve controls and the fourth nerve controls some of those vertical movements, but in reality, the connections are certainly the circuitry, right, that has the control of this stuff, you know,
00:18:10
Speaker
It's sort of like distributing the brainstem in a different way.
00:18:12
Speaker
So vertical eye movements, I think about the tectum, the upper eye movements, and then the lower medulla, they have some connections that go down.
00:18:20
Speaker
So that's what it means, is that you're testing really lower segments of the brainstem.
00:18:26
Speaker
People forget about these networks.
00:18:28
Speaker
They are subcortical.
00:18:30
Speaker
They are not easily testable.
00:18:33
Speaker
And that's why vertical eye movement is important.
00:18:35
Speaker
So basically, you move the head if the patient doesn't have C-spine injury.
00:18:38
Speaker
If there's no evidence of trauma, the spinal cord or the C-spine.
00:18:44
Speaker
So you move the head horizontally and then you do a head tilt maneuver and then you see if there are any vertical eye movements because if the medulla in the lower portion is still alive, right, or that still means that there's still some brain activity and that's what you want to eliminate.
00:19:02
Speaker
And that also applies for the 11th nerve, which is the spinal nerve that has
00:19:08
Speaker
some anatomical distribution that is extra foraminal, meaning it goes down into the spinal cord.
00:19:13
Speaker
You want to make sure that that level, it's not the 12th, right, it's the 11th, the one with the lowest level in the middle, that that level is totally absent.
00:19:21
Speaker
So it would be different, right, if you press on the head, you know, in the supraorbital area, for example, to produce a painful stimulation, and then the patient starts to move the shoulders or the neck in,
00:19:38
Speaker
in an unusual way, that's different, right, if I elicit the same response from a nail crush, because I know, right, the nail crush may be just a spinal cord mediated reflex, whereas if I elicit the same thing about the foramen magnum, I know that there's still some connection between that fifth nerve and the 11 causing this abnormal movement.
00:20:00
Speaker
So this is why, you know, you do,
00:20:03
Speaker
These lower segments of the medulla testing and vertical eye movements are one of them.
00:20:08
Speaker
Excellent.
00:20:09
Speaker
So I think that just to recap some valuable pearls for our audience, making sure that you go through the prerequisites.
00:20:17
Speaker
I mean, use a checklist in terms of drugs, making sure that it's five half-lives or more of any drug that can impact patients.
00:20:24
Speaker
the levels of consciousness, making sure that you examine above and below the poramen magnum in terms of making sure that you are eliminating any type of connection between, I mean, the brain and the rest of the body.
00:20:39
Speaker
And then finally, when you look at ocephalics, making sure that you're testing both for horizontal and vertical ocephalic reflexes, which sometimes can be deceiving in certain lesions.
00:20:50
Speaker
So those are all, I think, things that
00:20:52
Speaker
I'm sure a lot of our clinicians who are not doing this on a regular basis might forget once in a while.
00:20:57
Speaker
So I think very valuable to kind of recap.
00:21:01
Speaker
So once we have confirmed that we have a diagnosis of a devastating injury that's irreversible, we have eliminated any influence of external factors that are reversible.
00:21:13
Speaker
We've gone through our checklist.
00:21:14
Speaker
We did a thorough exam, and that is a
00:21:19
Speaker
consistent with brain death, the next step, like you said, would be to go for the apnea test.
00:21:25
Speaker
So tell us a little more about the apnea testing.
00:21:28
Speaker
So the apnea test in my mind is just a confirmation that there's really no brainstem or deencephalic activity that would elicit a respiration during a challenge of CO2.
00:21:43
Speaker
So CO2 is a very powerful stimulant of the deencephaline.
00:21:47
Speaker
And that's why you breathe even though you don't think you're breathing.
00:21:54
Speaker
And if you elevate the CO2 to a level that is usually considered more than 20 millimeters of mercury, which is not based on any empiric data, by the way.
00:22:07
Speaker
This is just expert opinion.
00:22:08
Speaker
But if you elevate the level substantially and more than 20 millimeters of mercury, you don't see any responses.
00:22:17
Speaker
then you are satisfied with the assumption that there is no brain activity.
00:22:24
Speaker
So that's what confirms this concept of cessation, whole cessation of brain function.
00:22:33
Speaker
the amnia test.
00:22:35
Speaker
And with the guideline and per the law, that's what satisfies the diagnosis of brain death.
00:22:41
Speaker
As long as you have gone through all of these prerequisites, very thorough neuroexam, right?
00:22:47
Speaker
And then finally, the amnia test.
00:22:48
Speaker
For the amnia test, you have to have also some considerations.

Consent and Communication in Brain Death Testing

00:22:53
Speaker
Your patient has to be normothermic, so you cannot do an amnia test in somebody that is hypothermic, that is resurfacing from
00:23:00
Speaker
hypothermia from cardiac arrest, for example.
00:23:02
Speaker
You have to have a... Or environmental, right?
00:23:04
Speaker
Or environmental hypothermia.
00:23:07
Speaker
Or environmental.
00:23:08
Speaker
Yeah, exactly.
00:23:09
Speaker
You have to rewound the patient.
00:23:11
Speaker
The systole blood pressure, believe it or not, according to the guideline, has to be more than 100 millimeters of mercury.
00:23:17
Speaker
And again, there is no data to support that, but it's biologically accepted that at that level you can still maintain perfusion.
00:23:28
Speaker
to structures in the brain.
00:23:28
Speaker
So that's one of the prerequisites.
00:23:30
Speaker
And then the other prerequisite is that you have to have very good pre-oxygenation.
00:23:36
Speaker
So before we do an amnia test, we usually pre-oxygenate our patients.
00:23:42
Speaker
We put it on FiO2 of 100% for a couple of minutes.
00:23:45
Speaker
And then having a baseline ABG that tells you
00:23:49
Speaker
that the patient oxygenation, usually more than 200 millimeters of mercury is what's recommended to perform anatomy test, because that's what's going to give you an idea if the patient is going to tolerate it or not.
00:24:00
Speaker
It wouldn't make sense to get one of your ARDS patients that has a PAO2-DF2 ratio of less than 100, right?
00:24:09
Speaker
And the patient wouldn't tolerate that.
00:24:12
Speaker
I mean, you will have to stop the test almost immediately because the
00:24:18
Speaker
reserve would be too low.
00:24:20
Speaker
So that's one of the reasons why that number is there.
00:24:23
Speaker
And then finally, you have to have a normal pH status, a normal acid-base status.
00:24:29
Speaker
A couple of things, I mean, Fred, to kind of talk a little bit more about the items you mentioned for the apnea testing.
00:24:36
Speaker
So clearly, I mean, there are patients that we won't be able to do an apnea test.
00:24:41
Speaker
So there are patients who you said who are too hypoxemic to tolerate a PIPA-5 or be off the ventilator, like severe RDS, who would not be candidates for an apnea test.
00:24:53
Speaker
There are patients who become hemodynamically unstable.
00:24:56
Speaker
Those will not be a candidate for an apnea test.
00:24:58
Speaker
So I think that's important to recognize that.
00:25:01
Speaker
An apnea test would be the logical next step in this determination, but sometimes it's not possible.
00:25:08
Speaker
And we'll talk a little bit more about what to do in those cases soon.
00:25:10
Speaker
But let me ask you another question, Fred.
00:25:13
Speaker
What constitutes, so you said a positive apnea test is when the patient fulfills all these criteria, we are able to disconnect them from the ventilator, we observe no breathing, and
00:25:26
Speaker
in a period of 8 to 10 minutes, and when we get a gas, either the PCO2 was over 60 or went by 20 or more above the baseline.
00:25:35
Speaker
And in those cases, we would call the apnea test positive, correct?
00:25:41
Speaker
That's correct.
00:25:41
Speaker
That's what the guideline suggests.
00:25:44
Speaker
And I think that a very important situation is that if we were to do this with a patient,
00:25:49
Speaker
By definition, at this point, that time would dictate the time of death for this patient.
00:25:56
Speaker
So when we filled the death certificate, it would be the time that we completed or proved that the apnea test was positive, which I think is something that sometimes people don't understand, especially with patients who then become organ donors or other things go on later.
00:26:11
Speaker
But let's talk a little bit, Fred, about an aborted apnea test.
00:26:16
Speaker
So when do you stop the apnea test?
00:26:19
Speaker
So when I see respirations, when I see the patient is taking a deep breath, we have recently one here in my institution where minute number five, he took a small breath, so we stopped the amnithesis.
00:26:34
Speaker
So that's one.
00:26:35
Speaker
If you see something that resembles arousal, suddenly the patient opens the eye, something like that, you have to be extremely
00:26:48
Speaker
careful and perhaps seasoned not to stop an amniotest when a patient starts having weird motor responses.
00:26:57
Speaker
And what I'm saying is that there are some spinal cord mediated phenomena that you could see
00:27:04
Speaker
in these patients and it's not related to the patient is waking up or not, it's related to the acid-base status that you are causing.
00:27:13
Speaker
You are basically causing an acidosis.
00:27:15
Speaker
A very quick elevation in CO2 will translate into a very quick lowering of your pH.
00:27:23
Speaker
And that acidosis, sometimes, not every patient, I've seen probably one in 12 years of practice,
00:27:30
Speaker
They may elicit weird muscular abnormalities.
00:27:33
Speaker
And you see that sometimes, you know, these myoclonic movements in patients with metabolic acidosis.
00:27:39
Speaker
So sometimes you could see these weird movements and you really have to be very seasoned, you know, to sort of like discern if this is a muscular response mediated to acidosis or not.
00:27:53
Speaker
You know, my take on apnea tests, right, is that, I'm sorry, on the whole brain death process,
00:27:59
Speaker
pathway, right, is that you really have to be sure.
00:28:04
Speaker
And if you are not sure, it's better to say, I'm aborting this test.
00:28:08
Speaker
If you see something abnormal, you're not comfortable with, right, it's just to better say, you know, I cannot really pronounce this patient because he, you know, had an extensor response.
00:28:21
Speaker
And you cannot really say that it was just final core mediated.
00:28:25
Speaker
It's just better to say, you know, I'm going to stop this.
00:28:27
Speaker
I'm going to continue.
00:28:28
Speaker
I cannot pronounce it.
00:28:30
Speaker
pick an ancillary testing.
00:28:32
Speaker
I think when in doubt, obviously you stop.
00:28:34
Speaker
And I think that it's also another reason why a lot of authors have recommended that when we do these apnea tests, we do not leave the patients hooked up to the ventilator because any movement could trigger a breath and fool you.
00:28:49
Speaker
So usually just having oxygen through a T-piece or just directly into the ET tube is a recommended method.
00:28:57
Speaker
strategy and for the person that is going to pronounce the patient to be present at the bedside making the observations and the determination I think is very important.
00:29:08
Speaker
Exactly.
00:29:08
Speaker
Yeah, no, we usually insert a cannula through the ET tube and we put 100% oxygen through it and patients that don't have any pulmonary abnormalities, they will tolerate that.
00:29:24
Speaker
But yeah, you have to disconnect it from the ventilator for sure.
00:29:28
Speaker
And I think that one of the things that the literature have shown, Fred, and what we discussed earlier is that the basic concept of brain death, the basic tenets of what is required to make that diagnosis are not that controversial.
00:29:44
Speaker
Where there's variability, I think, among the medical community is in the details of how certain things are done or not done, because like you said, we don't have a lot of
00:29:53
Speaker
randomized or prospective studies that have compared these ways of doing things one to another, and there is significant variability.
00:30:00
Speaker
And that's why I think it's important for clinicians not only to know the American Academy of Neurology recommendations, but to understand very thoroughly what is the guidelines or policies at their institution and also how those work with their local state laws, since there's some variations that we might get to later from state to state.
00:30:21
Speaker
Let me ask you another question regarding the apnea testing, which I think is something that a lot of people sometimes struggle with because the concept is easy, but then when you try to implement it, it becomes a little bit more problematic.
00:30:37
Speaker
What about consent, Fred?
00:30:39
Speaker
Do you need to get consent to do an apnea test?
00:30:42
Speaker
Yeah, so that question polarizes a lot of the providers.
00:30:46
Speaker
If you ask the question, do you need consent for an apnea test,
00:30:50
Speaker
It would polarize a group of intensivist providers or people that do this frequently.
00:30:56
Speaker
And the reason for the consent question is because you're going to basically perform a procedure that could
00:31:03
Speaker
actually have some complications during the procedure, right?
00:31:06
Speaker
So if you think about the consent process that we use in our patients that are alive, and by the way, you know, the patient is still alive when we're going to do an amnia test, then requesting permission to do something that could potentially harm the patient, right?
00:31:23
Speaker
The pressure can drop or, you know, something could happen to the patient, you know, he can code during the amnia test,
00:31:30
Speaker
It's very important.
00:31:31
Speaker
So you don't need written consent in my opinion.
00:31:34
Speaker
What you need to do is inform the family that you're gonna do this condition, I'm sorry, this procedure, this testing to document that there is no brain function as your last step
00:31:48
Speaker
to arrive to the conclusion of death and the neurological criterion.
00:31:51
Speaker
And perhaps the most important thing that you need to disclose, right, is not just that there could be complications, but that you're going to be there with a group of people that could actually, you know, take care of the complications, is that the outcome could be that the patient is going to be dead.
00:32:07
Speaker
That's for me the most important part of the disclosure of the whole process is that once I do this and I document that there is an elevation of more than 20 and the CO2 increased substantially and there was no response, is that the patient's gonna be declared dead because the community doesn't understand this concept very well.
00:32:25
Speaker
And if I tell you that sometimes when I have these discussions with families, they are like, okay, that's great, so what is next?
00:32:34
Speaker
And then you're like, well, your family member is going to be pronounced dead.
00:32:38
Speaker
What is next is that he's going to get disconnected from the ventilator and he's going to go to the morgue, right?
00:32:43
Speaker
They don't understand that.
00:32:45
Speaker
And this is why it's so important for you to tell them that the outcome is that they are going to get a documentation that they are dead and therefore everything stops, not just the medical care.
00:32:56
Speaker
Many things will stop once you document the patient is dead.
00:33:00
Speaker
I agree, and I think that a lot of the specifics for the process, if you look at the guidelines that we'll put at the show notes, the checkboxes are there.
00:33:10
Speaker
We all could go through that and make sure that you cover all those things.
00:33:13
Speaker
But part of the difficulty, I think, that arises with these cases, and there's been some very, very publicized cases where families refuse to accept this diagnosis, might be mitigated by how we approach families.
00:33:25
Speaker
And I think that I agree with you, Fred, 100%.
00:33:29
Speaker
Families should be aware of what's going on.
00:33:31
Speaker
What I usually try to do is to explain to them that there are two ways that we pronounce patients dead.
00:33:37
Speaker
One is when their heart and their lungs stop working, which I think most people understand very easily.
00:33:44
Speaker
But I also tell them that the other way is when the brain doesn't work, it also is considered dead.
00:33:50
Speaker
But in the case of this patient in the ICU, the heart and the lung continue because of the machines.
00:33:56
Speaker
So when we suspect that we might be able to tell the families, your loved one has devastating neurological injury from this process.
00:34:04
Speaker
We suspect that this patient, your loved one might be dead by what we called neurologic criteria or be brain dead.
00:34:11
Speaker
We're going to test for that.
00:34:12
Speaker
And I think it's a good lead way into saying we're going to do an apnea test and explain what it is.
00:34:17
Speaker
And it starts, I mean, preparing the family.
00:34:19
Speaker
And I think that the key here is to use a simple,
00:34:23
Speaker
the language as possible and be very clear in terms of what we're doing and what is happening.
00:34:29
Speaker
Like you said, Fred, I think can decrease the role of confusion because these are obviously, especially when they're younger people or unexpected problems, dramatic cases, tensions are very high.
00:34:42
Speaker
The emotions are very high.
00:34:44
Speaker
And I think it can become very confusing for a lot of families.
00:34:49
Speaker
Yeah.

Role of Ancillary Testing in Brain Death

00:34:51
Speaker
So let's say that we are unable to, so actually if we are able to confirm that the apnea test is positive, like we said, at that point based on the current laws that we have, right, and in most states you would document that the patient meets criteria for death by neurologic criteria or for brain death.
00:35:13
Speaker
If you can't do the apnea test, what are other options to try to get to this diagnosis?
00:35:20
Speaker
Yeah, so the concept of brain death is cessation of whole brain function, right?
00:35:26
Speaker
And what you need to understand that this is on the basis of total collapse of serial blood flow.
00:35:33
Speaker
So when you think about brain death as a condition, right, that translates into total cessation of blood flow, then it gives you an idea of what you can do to determine, right, if the patient is dead.
00:35:44
Speaker
So blood flow testing is in my mind one of the ancillary testings of tests that I would always try to get or consider.
00:35:55
Speaker
There are some
00:35:58
Speaker
studies that with electrophysiological testing like EEG, and they were part of the original definition of the syndrome.
00:36:06
Speaker
But in my mind, that is really not recommended nowadays, even though it's still part of the guideline that you could still use EEG.
00:36:14
Speaker
And some jurisdictions use electrophysiology.
00:36:18
Speaker
They continue CDG, SSCPs as part of their ancillary testing battery.
00:36:24
Speaker
In my mind, knowing that brain death and total cessation of brain function on the basis of serial blood flow collapse, then I am always trying to get a blood flow test.
00:36:36
Speaker
And the main ones that we have available nowadays are the nuclear scans with technicium.
00:36:46
Speaker
research, more empiric data suggests that, for example, transcranial dopplers are also very good.
00:36:52
Speaker
And the beauty of TCDs is that it's portable.
00:36:56
Speaker
So the problem that we have in the ICU sometimes is that the patient is too sick to do an amnia test, so we cannot do it.
00:37:03
Speaker
And then it's too sick to be transported to a different setting than the ICU for this blood flow testing.
00:37:11
Speaker
Cerebral angiogram is another one that you could consider, but again, the patient has to be transferred.
00:37:16
Speaker
There is some data on, you know, some reports, for example, using CTA, computed tomography and geography, and even MRAs.
00:37:27
Speaker
I don't think the sensitivity is that great that I would actually recommend CTA or MRAs.
00:37:35
Speaker
I think that
00:37:37
Speaker
Technetium and TCDs have the highest sensitivity.
00:37:41
Speaker
And as I said, it's the portability of TCDs that in my institution and in my practice, I always default to when I cannot do an ancillary test.
00:37:50
Speaker
And I think that โ€“ Go ahead.
00:37:51
Speaker
What I was going to say, Fred, is that a lot of our listeners obviously practice in large community hospitals.
00:37:57
Speaker
And I think that expertise with TCD might be more limited to centers that do it a lot.
00:38:03
Speaker
So obviously in the right hands, like you said, it has tremendous advantages, especially that it can go to the patient.
00:38:09
Speaker
But I do suspect that in most hospitals in the United States, probably an angiogram, a nuclear scan, or an EEG is what's most readily available.
00:38:17
Speaker
Would that be a fair statement?
00:38:20
Speaker
Yeah, you're right.
00:38:21
Speaker
And the problem with TCD is also the inter-observer variability.
00:38:26
Speaker
So there are patterns in the TCDs that you need to consider, not
00:38:33
Speaker
showing blood flow is not enough.
00:38:35
Speaker
You have to have a pattern and it's called reverberation of flow.
00:38:41
Speaker
That means that the flow is coming back out of the arteries that go and it has to be in the four vessels.
00:38:46
Speaker
So yes, so you know, TCDs, even though they offer an advantage logistically, they are not that prevalent because of what you're saying.
00:38:57
Speaker
Angiograms, in my mind, perhaps the gold standard, but
00:39:01
Speaker
In my institution, we cannot get angiograms from brain death patients, for example.
00:39:06
Speaker
And I think that one of the things that I noticed is that you used the term ancillary test.
00:39:11
Speaker
For much of the literature in the past, or when you speak with people in practice, you might hear people talk about a confirmatory test.
00:39:21
Speaker
Give me the distinction there, and which is the preferred term these days?
00:39:26
Speaker
I think, you know what, I don't know, Sergio.
00:39:29
Speaker
I think the terms are used interchangeably and ancillary testing.
00:39:36
Speaker
I think it's what the guideline sort of like defines this test as.
00:39:42
Speaker
A confirmatory test, you know, in my mind is the amnio test, you know?
00:39:47
Speaker
That's what confirms at the bedside, you know, that there is no, you know, deencephalic function.
00:39:56
Speaker
And I guess the point I was getting to is that none of these are gold standards, these ancestry tests.
00:40:03
Speaker
And the gold standard really is, as you mentioned, the examination of the patient and the apnea test, right?
00:40:09
Speaker
And these can help you get more data points.
00:40:13
Speaker
But ultimately, like you said, I mean, the reason why I think the guidelines are using or pushing the concept ancillary is because none of these are a gold standard by themselves and that you need to do the other steps.
00:40:22
Speaker
And it's only when you cannot do the apnea test and you want more information to be sure or some, I guess, hospital protocols, they might include these.
00:40:32
Speaker
But again, I mean, like you said, I mean, these are ancillary tests to give you a little more data.
00:40:37
Speaker
Is there ever a role to do more than one test, more than one ancillary test, or you just go with one and the one that you think is most appropriate for your patient and based on your institution's expertise?
00:40:47
Speaker
Yeah, I would just use the one that you have available where you have more experience with.
00:40:56
Speaker
I don't think that you should be doing many ancillary tests at the same time.
00:41:01
Speaker
You will get confused.
00:41:05
Speaker
with the results, you may get false negatives, false positives.
00:41:09
Speaker
I mean, you may be confused.
00:41:11
Speaker
As you were saying, in reality, the gold standard is the clinical exam and the amnia test.
00:41:17
Speaker
And then, by the way, the American Academy of Neurology, it's sort of like the position is that you should try to do everything possible to document this exam or to arrive to the conclusion of death by neurological criteria.
00:41:33
Speaker
with just a clinical exam and the apnea test.
00:41:36
Speaker
Yeah, and I think that, go ahead.
00:41:39
Speaker
Yeah, there are some jurisdictions, perhaps more in Europe or in Latin America, where they require you by law to have the clinical exam, the apnea test, and an ancillary testing.
00:41:52
Speaker
And perhaps you may be working in an institution that requires both, I don't know, because the law,
00:41:57
Speaker
basically says it's up to the provider, right?
00:42:00
Speaker
That means perhaps up to a committee in the institution to define what is your battery of testing that you want to do for a patient to arrive

Legal and Institutional Nuances of Brain Death

00:42:09
Speaker
to that conclusion.
00:42:09
Speaker
So in a hospital, you know, even in the United States or in the state, you know, you may be required by law, right?
00:42:16
Speaker
Though I'm not aware that you may require both the clinical, the apnea, and also the ancillary testing.
00:42:24
Speaker
And I think that we mentioned earlier, but I think it's worth repeating for our audience.
00:42:28
Speaker
There really are a couple of levels in terms of what to do.
00:42:33
Speaker
So the law, the federal law in the United States, is
00:42:38
Speaker
allows people to be declared dead based on a neurologic condition, and the law establishes that the criteria for those conditions are based on the medical standard.
00:42:50
Speaker
There are some specific variations in some state laws that allow for some provisions or some exemptions, but basically it's still very similar.
00:43:00
Speaker
And then you have really two more levels of medical knowledge.
00:43:04
Speaker
One is what the guidelines say.
00:43:06
Speaker
And like Fred said, the American Academy of Neurology is really the predominant guideline that people have endorsed.
00:43:14
Speaker
And they very clearly tell you that it's the examination, so the right setting, the examination, and the apnea test, that is all that's needed.
00:43:22
Speaker
If those are conclusive, you can declare somebody brain dead.
00:43:26
Speaker
The ancillary testing is only recommended when you cannot
00:43:30
Speaker
perform a apnea test or it's aborted or the exam is inconclusive because you cannot perform an exam and we'll talk about that in a second.
00:43:40
Speaker
And then finally, I think it's very important for our providers to be familiar with what are the policies and guidelines for their institution and what does the law say at their state.
00:43:54
Speaker
So having practiced in New Jersey, it is very well known that
00:43:58
Speaker
that New Jersey has a very clear exemption based on religious beliefs that allows families to present that, and the patient cannot be declared dead by neurologic criteria.
00:44:10
Speaker
But that's a very specific situation to New Jersey.
00:44:13
Speaker
So I think that I would encourage our listeners to really understand what are the local laws, but also what are the local laws.
00:44:20
Speaker
policies at their institution.
00:44:22
Speaker
Who can do the test?
00:44:24
Speaker
How do they do the test?
00:44:25
Speaker
What is required?
00:44:26
Speaker
So they make sure they comply with all those requirements.

Avoiding Misdiagnosis in Brain Death

00:44:30
Speaker
Before we move on to some special circumstances, Fred, I wanted to ask you about situations that might mimic brain death that actually we have to be careful with.
00:44:41
Speaker
I'm sure they're very rare, but any situations in particular that come to mind?
00:44:47
Speaker
Yeah, so the ones that we mentioned at the beginning where we want to really be careful, you know, and for which we have a checklist, right?
00:44:56
Speaker
Any metabolic condition, you know, that would cause transient cessation of brain activity.
00:45:03
Speaker
So intoxication with drugs, you know, sort of like the main one that I'm thinking.
00:45:08
Speaker
Exposure to analgesics and sedatives, right?
00:45:12
Speaker
We use a lot of, believe it or not, a lot of pentobarbital for management of ICP in a neurological patient.
00:45:19
Speaker
So, you know, once you give pentobarb a sufficient dose, you will basically, you know, mimic, you know, a brain death exam.
00:45:30
Speaker
Your patient will have no neurological activity whatsoever, and they will have isoelectrical, I'm sorry,
00:45:38
Speaker
Electronegative silence is what I'm saying in the EEG.
00:45:42
Speaker
So all of those are in my mind.
00:45:44
Speaker
And then things,
00:45:47
Speaker
like the locked-in syndrome, which is the one that I always get concerned about, where you will have a patient that looks comatose but is in reality aware.
00:46:00
Speaker
So knowing how to test and examine these patients is extremely important.
00:46:04
Speaker
When I'm examining a comatose patient, I usually open their eyes with my hands and I try to communicate and see if there's any response.
00:46:12
Speaker
Vertical eye movements is the one that I'm looking for.
00:46:15
Speaker
But again, these patients usually have very localized injuries in the brainstem.
00:46:21
Speaker
So you will see them in the imaging, that there's really no major supratentorial brain injury that could explain the exam.
00:46:29
Speaker
So you have to be a little more concerned.
00:46:32
Speaker
But those are primarily the ones, intoxications and the Loctin syndrome.
00:46:37
Speaker
Excellent.
00:46:38
Speaker
So I think that as we start wrapping up, I guess the last topic that I wanted to touch about brain death is the special circumstances that are becoming more prevalent as we evolve and the way we provide critical care.

Special Cases in Brain Death Diagnosis

00:46:51
Speaker
So the two specific that I wanted to ask you, you can just give us some very targeted comments on patients who are post-cardiac arrest who get targeted temperature management for anoxic brain injury and patients who are on ECMO or extracorporeal membrane oxygenation.
00:47:08
Speaker
Yeah, so for the first cohort, the patient post-ETM after cardiac arrest, you know, you have to be more careful because hypothermia has changed, you know, the way that these patients look like.
00:47:25
Speaker
And the prognosis also has changed a lot with exposure to hypothermia post-cardic arrest.
00:47:30
Speaker
Now, in my practice, right, we sort of like know it once we see it.
00:47:39
Speaker
We have a patient with cardiac arrest with a prolonged time to ROSC with an imaging that shows already some serial edema, which may be substantial, a lot of effacement in the sulci and the gray, white matter areas.
00:48:01
Speaker
And then once they start resurfacing from hypothermia to normal temperatures, then when you're examining them serially, you start thinking, I don't think this is going in the right direction.
00:48:15
Speaker
This patient is perhaps dead.
00:48:20
Speaker
So I usually wait the first 24 hours of hypothermia.
00:48:23
Speaker
My patient has been hypothermic down to 33.
00:48:26
Speaker
If you are at 36, it's a little different.
00:48:28
Speaker
You can actually move faster.
00:48:30
Speaker
but I usually wait a couple of hours after I get the patient back to a normal thermic range.
00:48:35
Speaker
I exclude with the checklist any possibility of exposure to sedatives or organ dysfunctions that could preclude the exam of brain death.
00:48:48
Speaker
And then after I go through the checklist, I examine the patient in a thorough way.
00:48:56
Speaker
But again, it's sort of like this,
00:49:00
Speaker
feeling that you have that you know the patient is not going to turn out well.
00:49:09
Speaker
I think it's something with the experience.
00:49:12
Speaker
But I wouldn't try to do an exam up front.
00:49:18
Speaker
Most of the patients that have cardiac arrest that come to the emergency department, they look brain dead.
00:49:24
Speaker
They have no brain activity whatsoever.
00:49:29
Speaker
So unless I know the patient has been down for a while and they're just trying to resuscitate somebody that looks dead from the beginning, I probably will not attempt a brain dead exam up front.
00:49:45
Speaker
I will let him go through the whole process and then do my neuro-pagnostication after they're re-warm.
00:49:51
Speaker
For the ECMO patient, it's a little bit more difficult because they have total artificial
00:49:58
Speaker
circulation.
00:50:00
Speaker
And there's been some attempts that sort of mimicking the amnia test with CO2 challenges by infusing CO2 in these patients.
00:50:12
Speaker
But in reality, I think that the blood flow studies are probably the way of going around the normal pathway in these patients.
00:50:25
Speaker
You cannot examine these patients on
00:50:29
Speaker
on ECMO because you are not gonna have the opportunity of performing a conventional amnia testing.
00:50:34
Speaker
So can you infuse CO2 via the ECMO machine and sort of like mimic or simulate the challenge?
00:50:42
Speaker
And the answer is there, a couple of reports.
00:50:44
Speaker
I think the one that I can think about is from the major clinic that try to do this and sort of like, but not every institution has that experience or availability.
00:50:54
Speaker
What we have done at my institution is TCDs.
00:50:57
Speaker
So, transpinal dopplers can help because they are portable.
00:51:03
Speaker
You don't need to get these patients with all this machinery down to the angiosuite or the nuclear suite.
00:51:13
Speaker
And you can do a
00:51:18
Speaker
a quick assessment of a blow flow with those patients.
00:51:20
Speaker
And as I said, you have to look for the pattern, which is reverberation in the four vessels.
00:51:26
Speaker
So it's interesting, like you said, I mean, with the post-cardiac arrest patients who underwent targeted temperature management, obviously it's about making sure that the timing of the assessment is appropriate.
00:51:38
Speaker
We had a whole discussion on neuroprognostication in this population with you a year ago, so I'll make sure that I link that episode to the podcast.
00:51:47
Speaker
show notes if people are interested.
00:51:49
Speaker
And with ECMO, I think the challenge, obviously, is the apnea test.
00:51:52
Speaker
There are some reports, like you mentioned, Fred, where people have used the ECMO machinery in the sweep to titrate or simulate the apnea test and see if that stimulates bleeding.
00:52:02
Speaker
But it seems that this is a case where an ancillary testing up front would probably make much more sense in terms of trying to get that determination.
00:52:11
Speaker
Correct.
00:52:13
Speaker
Excellent.
00:52:13
Speaker
Well, I think that it's been a very interesting discussion.

Conclusion: Compassionate Care in Brain Death

00:52:17
Speaker
As I said before we started recording, I didn't want to dive into all the cases and controversies that have arisen over the last several years.
00:52:26
Speaker
People can look those up.
00:52:28
Speaker
I'm sure that a lot of people have experienced families that refuse to accept a diagnosis.
00:52:33
Speaker
and the legal battles in that respect have been well publicized in the press.
00:52:37
Speaker
But I do think that it's important to just review what we know about the clinical performance of this determination, what's the science available, and make sure that we provide our listeners with some good tools that we'll share in the podcast notes so they can educate themselves.
00:52:57
Speaker
This is something I think that
00:52:58
Speaker
happens in every ICU every year at least a couple of times and in very large centers can happen multiple times in a single year.
00:53:08
Speaker
One of the things that I also wanted to
00:53:12
Speaker
To do before we end is make sure you had shared in one of the chapters that you wrote, Fred, with me that there is a website from the Society of Neurocritical Care that really has a toolkit and a lot of education material that I think is very valuable.
00:53:28
Speaker
So I'll make sure that I put that in the show notes as well so our audience can go and check that out.
00:53:36
Speaker
You've been through this before.
00:53:38
Speaker
You know the drill, Fred, at the end.
00:53:39
Speaker
We kind of tap into your wisdom.
00:53:42
Speaker
So a couple of closing questions.
00:53:44
Speaker
The last time you were on the podcast, I asked you about books that were very influential, and you had mentioned Meditations by Marcos Aurelius, which happens to be also one of my most important books in terms of one that I try to read every year at least once.
00:53:58
Speaker
So I'm going to have to change the question today.
00:54:00
Speaker
If you were on a desert island and could only listen to one music album, which one would it be?
00:54:07
Speaker
So I hope in the island they have a USB connection so I can connect my iPhone to my iPod.
00:54:13
Speaker
It'll have to be vinyl.
00:54:14
Speaker
Vinyl, old school.
00:54:18
Speaker
Yeah, so there is one album that I love and it's Nevermind by Nirvana, 1991.
00:54:24
Speaker
And the reason why I love it so much is because that's the year when I got into medical school and the year where I had my first girlfriend.
00:54:33
Speaker
Believe it or not, I never had a girlfriend.
00:54:35
Speaker
I got my first girlfriend in medical school.
00:54:39
Speaker
And the best song is Come As You Are.
00:54:43
Speaker
We will include that in the show notes.
00:54:44
Speaker
I think that a lot of our audience might be too young to remember Rain and Nirvana.
00:54:51
Speaker
But definitely, I think, a phenomenal album.
00:54:54
Speaker
And I do have the vinyl.
00:54:55
Speaker
So I definitely will.
00:54:56
Speaker
Oh, you do?
00:54:57
Speaker
Oh, my gosh.
00:54:58
Speaker
You're lucky.
00:54:59
Speaker
It's an awesome album.
00:54:59
Speaker
I agree.
00:55:00
Speaker
So my second question relates to failure.
00:55:04
Speaker
We seem to always be fearful of failure, but I believe that failure should be embraced since it often is the best teacher that we have in life.
00:55:10
Speaker
Could you share with us a really good failure, one that really taught you something valuable?
00:55:17
Speaker
You know, talking about death and life situations, right, you know, one of my fears, right, in the intensive care unit, and we have talked about this before, right,
00:55:31
Speaker
It's the failure of being compassionate.
00:55:34
Speaker
And we have talked about this because of our experiences with mentors before.
00:55:43
Speaker
I fear failing in terms of being compassionate at the end of life.
00:55:50
Speaker
And it's something like the struggles that I have and it's
00:55:55
Speaker
If you're a physician in the ICU, it's not bad to go home and then cry a little bit about not being able to help somebody because you have failed miserably at being compassionate with that patient or family.
00:56:09
Speaker
So over the last five years, I've been changing the way that I approach these topics in the ICU with families.
00:56:18
Speaker
You know, sort of like discussing them at the same level with families is what I try to do.
00:56:23
Speaker
And failing to do that is what I'm afraid the most.
00:56:26
Speaker
So I think that this is definitely something that touches all of us who listen to critical matters and work in the ICU is recognizing that no matter how compassionate we believe we are, we probably have failed some patients.
00:56:39
Speaker
And recognizing that and learning from those experiences, I think, is instrumental in becoming better physicians and better providers for our patients.
00:56:48
Speaker
So the last question is, is there anything in particular specific that you would want every listener to our podcast to know?
00:56:57
Speaker
Could be a quarter specific fact of what we talked about.
00:57:01
Speaker
No, I think I will go back to their first podcast.
00:57:09
Speaker
I think that knowing death is an alternative as well and it could be a good outcome.
00:57:15
Speaker
Knowing that it's extremely important in the field.
00:57:18
Speaker
that we practice.
00:57:19
Speaker
So that doesn't have to be the worst outcome.
00:57:22
Speaker
It could also be a good outcome.
00:57:24
Speaker
And trying to understand the suffering from the patient and the family to better explain that when you think everything is just not going well, it's an extremely important thing that I would like everyone to know.
00:57:41
Speaker
Excellent.
00:57:42
Speaker
Fred, as usual, always a pleasure to talk with you.
00:57:45
Speaker
Thank you so much for being generous with your time and your knowledge.
00:57:49
Speaker
And we definitely, I mean, look forward to having you back on Critical Matters as one of our recurrent guests.
00:57:55
Speaker
Thank you very much.
00:57:57
Speaker
Thank you, Sergio.
00:58:01
Speaker
Thanks again for listening to Critical Matters.
00:58:03
Speaker
Make sure to subscribe to this podcast on iTunes or Google Play.